Status:
COMPLETED
Impact of Dialysis Modality on Coagulation and Platelet Function
Lead Sponsor:
Seoul National University Hospital
Conditions:
Renal Replacement Therapy
Eligibility:
All Genders
19+ years
Brief Summary
The investigators will evaluate the impact of dialysis modality (intermittent hemodialysis or continuous renal replacement therapy) in coagulation and platelet function in critically ill patients
Detailed Description
An prospective observational study will be conducted to confirm the impact of two dialysis modalitites on coagulation and platelet function in critically ill patients requiring renal replacement thera...
Eligibility Criteria
Inclusion
- • Critically ill adult patients in surgical intensive care unit who require renal replacement therapy
Exclusion
- Patients treated with anti-coagulation therapy due to thrombosis/embolism
- Patients who take anti-platelet drug due to cardiac or cerebrovascular diseased
- Patients treated with pharmacological prophylaxis of deep vein thrombosis
- Patients who received blood products within 24 hours of dialysis initiation
- Patients who do not want life-sustaining care including renal replacement therapy
Key Trial Info
Start Date :
August 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04512131
Start Date
August 4 2020
End Date
June 30 2023
Last Update
December 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, Jongno-gu, South Korea, 03080